Evolent Health Stock Forecast

Stock Price Forecast

The 14 analysts with 12-month price forecasts for Evolent Health stock have an average target of 7.93, with a low estimate of 3.00 and a high estimate of 18. The average target predicts an increase of 125.93% from the current stock price of 3.51.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$3.00	$7.93	$7.00	$18
Change	-14.53%	+125.93%	+99.43%	+412.82%

Analyst Ratings

The average analyst rating for Evolent Health stock from 15 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	7	7	7	7	7	7
Buy	7	6	6	6	5	5
Hold	1	1	1	1	3	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	15	14	14	14	15	15

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Michael Wiederhorn Oppenheimer	Oppenheimer	Buy Maintains $12 → $6	Buy	Maintains	$12 → $6	+70.94%	Mar 2, 2026
Daniel Grosslight Citigroup	Citigroup	Strong Buy Maintains $6 → $4	Strong Buy	Maintains	$6 → $4	+13.96%	Feb 26, 2026
Kevin Caliendo UBS	UBS	Strong Buy Maintains $10 → $5	Strong Buy	Maintains	$10 → $5	+42.45%	Feb 26, 2026
Jailendra Singh Truist Securities	Truist Securities	Strong Buy Maintains $10 → $6	Strong Buy	Maintains	$10 → $6	+70.94%	Feb 26, 2026
Matthew Shea Needham	Needham	Strong Buy Maintains $15 → $4	Strong Buy	Maintains	$15 → $4	+13.96%	Feb 25, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

2.50B

from 1.88B

33.03%

from 1.88B

Revenue Next Year

2.90B

from 2.50B

16.03%

from 2.50B

EPS This Year

0.27

from -5.07

EPS Next Year

0.45

from 0.27

66.14%

from 0.27

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	907.96M	1.35B	1.96B	2.55B	1.88B	2.50B	2.90B
Revenue Growth	-1.80%	48.91%	45.26%	30.09%	-26.56%	33.03%	16.03%
EPS	-0.44	-0.20	-1.28	-0.81	-5.07	0.27	0.45
EPS Growth	-	-	-	-	-	-	66.14%
Forward PE	-	-	-	-	-	12.92	7.78
No. Analysts	-	-	-	-	-	17	15

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	2.7B	3.4B
Avg	2.5B	2.9B
Low	2.3B	2.5B

Revenue Growth

Revenue Growth	2026	2027
High	44.2%	34.9%
Avg	33.0%	16.0%
Low	20.3%	2.1%

EPS Forecast

EPS	2026	2027
High	0.82	0.65
Avg	0.27	0.45
Low	0.10	0.29

EPS Growth

EPS Growth	2026	2027
High	-	139.6%
Avg	-	66.1%
Low	-	8.2%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.